Linzess (Linaclotide)

Linaclotide is a medicine used to treat long-lasting constipation and irritable bowel syndrome with constipation. It is a capsule taken by mouth once a day, before a meal. It works by bringing more water into the gut, which makes stools softer and easier to pass.

Brand names:Linzess
Medication

What people taking Linzess (Linaclotide) report

Every report comes from a Lived member, sent anonymously.

Have you tried Linzess (Linaclotide) for IBS (Irritable Bowel Syndrome)?

NameHow it went

About Linzess (Linaclotide)

What It's For

Linaclotide, sold as Linzess, is a prescription capsule for long-term constipation, taken once a day. It is approved for three groups: adults and children 7 and older with irritable bowel syndrome with constipation (IBS-C), adults with chronic idiopathic constipation (CIC), and children 2 and older with functional constipation. IBS-C combines infrequent or hard stools with recurring belly pain and bloating. CIC and functional constipation mean ongoing constipation without a specific underlying cause such as a bowel blockage or another medicine. In US gastroenterology guidelines, linaclotide is a strongly recommended option for adults with IBS-C and for adults with CIC. For CIC, the same guidelines also strongly recommend several other choices, including the laxative polyethylene glycol.

How It Works

Linaclotide is a small protein-like molecule that acts on the lining of the intestine and is barely absorbed into the bloodstream. It switches on a receptor called guanylate cyclase-C, which the gut normally uses to control how much fluid it releases. When that receptor is activated, the intestine pumps salt and water into the bowel. The extra fluid softens stool and helps it move through faster, which is why bowel movements become easier and more frequent. In animal studies, the same signal also calmed pain-sensing nerves in the gut, which may help explain why belly pain improves for some people with IBS-C. That part of the effect is less well understood in people.

Dosage & Administration

Linzess comes as capsules in three strengths (72, 145 and 290 micrograms), and the strength depends on the condition and age. It is taken once a day on an empty stomach, at least 30 minutes before a meal, at about the same time each day. Many people take it before breakfast. Swallow the capsule whole and do not crush or chew the capsule or the beads inside. For anyone who cannot swallow capsules, the capsule can be opened and the beads sprinkled on a teaspoon of applesauce or swirled in bottled water and taken right away, or given through a feeding tube as the medication guide describes. If a dose is missed, skip it and take the next one at the usual time rather than taking two together. Keep the capsules in their original bottle with the moisture-absorbing packet, tightly closed.

Side Effects

Diarrhea is by far the most common side effect. In adult IBS-C trials it affected about one in five people taking the 290 microgram dose, compared with about one in thirty on placebo, and it usually started within the first two weeks. Belly pain, gas and bloating are also common. Lower doses tend to cause less diarrhea, so a dose change is often the first step if it is a problem. Severe diarrhea can lead to dehydration and low levels of salts such as potassium and sodium, and some people have needed IV fluids or a hospital stay. If you have severe diarrhea, or unusual or severe belly pain, stop linaclotide and contact your prescriber right away, especially if your stools are bloody or black. Feeling dizzy or faint along with heavy diarrhea is a sign of dehydration that needs to be checked the same day.

Interactions & Warnings

Linzess has a boxed warning, the most prominent warning the US Food and Drug Administration (FDA) puts on a medicine: it must not be given to children under 2. In very young animals, a single adult-sized dose caused deaths from dehydration. Because a child could swallow a capsule by accident, store it securely out of reach of children and get rid of unused capsules. Linaclotide should not be used by anyone with a known or suspected bowel blockage, so new severe pain, vomiting or a swollen belly before starting needs a clinician's assessment first. Because almost none of the drug enters the bloodstream, it has few known interactions with other medicines, but tell your prescriber about laxatives or other bowel medicines you use, since combining them can add to diarrhea. Linaclotide is not expected to reach a developing baby or breast milk, although data in pregnancy are limited, so discuss it if you are pregnant or planning to be.

What to Expect

Bowel movements often change quickly. In trials, the largest gain in bowel movement frequency came within the first week. Belly pain in IBS-C tends to ease more gradually, starting in the first week and reaching its fullest effect around six to nine weeks. Not everyone responds; in the adult IBS-C trials, a meaningful share of people improved on placebo too, and only some on linaclotide met the trials' strict combined measure of better pain and better bowel habits. Linaclotide controls symptoms rather than curing the underlying condition. When people stopped it in a trial, symptoms returned toward where they started within about a week, without rebounding worse. Many people therefore take it long term, and in long-term studies nearly a third of people had their dose lowered or paused, mostly because of diarrhea. Follow-up visits are a chance to adjust the dose or switch to another option if it is not working well.

Questions to Ask Your Doctor

  1. 1.Why is linaclotide a better fit for me than an over-the-counter laxative or another prescription option?
  2. 2.Which dose is right for my condition, and would a lower dose help if I get diarrhea?
  3. 3.How long should I give it before deciding whether it is working?
  4. 4.What should I do if I get severe diarrhea or feel dizzy, and should I stop other laxatives while taking it?
  5. 5.Is it reasonable to keep taking it long term, including if I become pregnant or am breastfeeding?

Last reviewed • Oct 2026

Educational content, not medical advice.